Corpus ID: 18294631

MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype

  title={MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype},
  author={C. Blenkiron and L. Goldstein and N. Thorne and I. Spiteri and S. Chin and Mark J Dunning and N. Barbosa-Morais and A. Teschendorff and A. Green and I. Ellis and S. Tavar{\'e} and C. Caldas and E. Miska},
  • C. Blenkiron, L. Goldstein, +10 authors E. Miska
  • Published 2007
  • Medicine
  • Experimental design Bead-based flow-cytometric miRNA profiling is relatively novel, with only few publications utilizing the platform to date [56, 97]. We therefore designed the experiment in a manner that allowed us to investigate technical effects and assess the reproducibility of measurements for a given probe or target sample. As described in [56] probes were coupled to colour-coded polystyrene beads allowing the simultaneous detection of about 90 different target oligonucleotides. To… CONTINUE READING
    57 Citations
    miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
    • 286
    • Highly Influenced
    • PDF
    MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
    • 454
    MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer
    • 39
    Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
    • 86
    • PDF
    MicroRNA expression profiling of male breast cancer
    • 110
    • Highly Influenced
    MicroRNA expression in canine mammary cancer
    • 66
    • Highly Influenced
    • PDF
    Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
    • 373
    • PDF
    Intratumoral heterogeneity of microRNA expression in breast cancer.
    • 35
    PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes
    • 25
    Small is beautiful: microRNAs and breast cancer—where are we now?
    • 73